Archimed acquires PET radiopharmaceuticals company IRAB

IRAB, founded in 2016 and headquartered in Barcelona, develops and produces PET radiopharmaceuticals for clinical diagnosis, clinical trials and biomedical research.

ByPE Hub Staff

9 June 2026•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Europe Healthcare Briefs

Archimed acquires PET radiopharmaceuticals company IRAB

ArchiMed